[Physiopathology and therapy of progressive systemic sclerosis].
Kondo
H
H
D018501:Antirheumatic Agents / Q000627:therapeutic use; D015551:Autoimmunity; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008019:Life Style; D008297:Male; D011379:Prognosis; D012595:Scleroderma, Systemic / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D018501:Antirheumatic Agents; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents